Abstrakt

Przypisy

• 1. Acedo P., Stockert J.C., Cañete M., Villanueva A.: Two combinedphotosensitizers: a goal for more effective photodynamic therapyof cancer. Cell Death Dis., 2014; 5: e1122
  Google Scholar
• 2. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., GollnickS.O., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D., Korbelik M.,Moan J., Mroz P., Nowis D., Piette J., et al.: Photodynamic therapy ofcancer: an update. CA Cancer J. Clin., 2011; 61: 250-281
  Google Scholar
• 3. Arenas Y., Monro S., Shi G., Mandel A, McFarland S, Lilge L.: Photodynamicinactivation of Staphylococcus aureus and methicillin-resistantStaphylococcus aureus with Ru(II)-based type I/type II photosensitizers.Photodiagnosis Photodyn. Ther., 2013; 10: 615-625
  Google Scholar
• 4. Babilas P., Schreml S., Landthaler M., Szeimies R.M.: Photodynamictherapy in dermatology: state of the art. Photodermatol. Photoimmunol.Photomed., 2010; 26: 118-132
  Google Scholar
• 5. Berg K., Folini M., Prasmickaite L., Selbo P.K., Bonsted A., EngesaeterB.Ø., Zaffaroni N., Weyergang A., Dietze A., MaelandsmoG.M., Wagner E., Norum O.J., Høgset A.: Photochemical internalization:a new tool for drug delivery. Curr. Pharm. Biotechnol., 2007;8: 362-372
  Google Scholar
• 6. Berg K., Selbo P.K., Prasmickaite L., Tjelle T.E., Sandvig K., MoanJ., Gaudernack G., Fodstad O., Kjølsrud S., Anholt H., Rodal G.H.,Rodal S.K., Høgset A.: Photochemical internalization: a novel technologyfor delivery of macromolecules into cytosol. Cancer Res.,1999; 59: 1180-1183
  Google Scholar
• 7. Bonnett R., Krysteva M.A., Lalov I.G., Artarsky S.V.: Water disinfectionusing photosensitizers immobilized on chitosan. Water Res.,2006; 40: 1269-1275
  Google Scholar
• 8. Bozzini G., Colin P., Betrouni N., Nevoux P., Ouzzane A., Puech P.,Villers A., Mordon S.: Photodynamic therapy in urology: what can we do now and where are we heading? Photodiagnosis Photodyn.Ther., 2012; 9: 261-273
  Google Scholar
• 9. Brackett C.M., Gollnick S.O.: Photodynamic therapy enhancementof anti-tumor immunity. Photochem. Photobiol. Sci., 2011;10: 649-652
  Google Scholar
• 10. Brovko L.: Photodynamic treatment: a new efficient alternativefor surface sanitation. Adv. Food Nutr. Res., 2010; 61: 119-147
  Google Scholar
• 11. Calzavara-Pinton P., Rossi M.T., Sala R., Venturini M.: Photodynamicantifungal chemotherapy. Photochem. Photobiol. 2012;88: 512-522
  Google Scholar
• 12. Castano A.P., Demidova T.N., Hamblin M.R.: Mechanisms in photodynamictherapy: part one-photosensitizers, photochemistry andcellular localization. Photodiagnosis Photodyn. Ther., 2004; 1: 279-293
  Google Scholar
• 13. Castano A.P., Mroz P., Hamblin M.R.: Photodynamic therapy andanti-tumour immunity. Nat. Rev. Cancer, 2006; 6: 535-545
  Google Scholar
• 14. Cho Y., McQuade T., Zhang H., Zhang J., Chan F.K.: RIP1-dependentand independent effects of necrostatin-1 in necrosis and T cellactivation. PLoS One, 2011; 6: e23209
  Google Scholar
• 15. Christofferson D.E., Li Y., Hitomi J., Zhou W., Upperman C., ZhuH., Gerber S.A., Gygi S., Yuan J.: A novel role for RIP1 kinase in mediatingTNFα production. Cell Death Dis., 2012; 3: e320
  Google Scholar
• 16. Costa L., Faustino M.A., Neves M.G., Cunha A., Almeida A.: Photodynamicinactivation of mammalian viruses and bacteriophages.Viruses, 2012; 4: 1034-1074
  Google Scholar
• 17. Cotter T.G.: Apoptosis and cancer: the genesis of a research field.Nat. Rev. Cancer, 2009; 9: 501-507
  Google Scholar
• 18. Dabrowski J.M., Arnaut L.G., Pereira M.M., Monteiro C.J.,Urbańska K., Simões S., Stochel G.: New halogenated water-solublechlorin and bacteriochlorin as photostable PDT sensitizers: synthesis,spectroscopy, photophysics, and in vitro photosensitizingefficacy. Chem. Med. Chem., 2010; 5: 1770-1780
  Google Scholar
• 19. Dabrowski J.M., Arnaut L.G., Pereira M.M., Urbańska K., StochelG.: Improved biodistribution, pharmacokinetics and photodynamicefficacy using a new photostable sulfonamide bacteriochlorin. Med.Chem. Commun., 2012; 3: 502-505
  Google Scholar
• 20. Dabrowski J.M., Urbanska K., Arnaut L.G., Pereira M.M., AbreuA.R., Simões S., Stochel G.: Biodistribution and photodynamic efficacyof a water-soluble, stable, halogenated bacteriochlorin againstmelanoma. Chem. Med. Chem., 2011; 6: 465-475
  Google Scholar
• 21. Daniels M.A., Jameson S.C.: Critical role for CD8 in T cell receptorbinding and activation by peptide/major histocompatibilitycomplex multimers. J. Exp. Med., 2000; 191: 335-346
  Google Scholar
• 22. de Vree W.J., Essers M.C., De Bruijn H.S., Star W.M., Koster J.F.,Sluiter W.: Evidence for an important role of neutrophils in theefficacy of photodynamic therapy in vivo. Cancer Res., 1996; 56:2908-2911
  Google Scholar
• 23. de Vree W.J., Essers M.C., Koster J.F., Sluiter W.: Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-basedphotodynamic therapy of rat rhabdomyosarcoma tumors. CancerRes., 1997; 57: 2555-2558
  Google Scholar
• 24. Dolmans D.E., Fukumura D., Jain R.K.: Photodynamic therapyfor cancer. Nat. Rev. Cancer, 2003; 3: 380-387
  Google Scholar
• 25. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D.,Korbelik M,. Moan J., Peng Q.: Photodynamic therapy. J. Natl. Cancer.Inst., 1998; 90: 889-905
  Google Scholar
• 26. Erental A., Sharon I., Engelberg-Kulka H.: Two programmed celldeath systems in Escherichia coli: an apoptotic-like death is inhibitedby the mazEF-mediated death pathway. PLoS Biol., 2012; 10: e1001281
  Google Scholar
• 27. Fabris C., Valduga G., Miotto G., Borsetto L., Jori G., GarbisaS., Reddi E.: Photodensitization with zinc (II) phthalocyanine asa switch in the decision between apoptosis and necrosis. CancerRes., 2001; 61: 7495-500
  Google Scholar
• 28. Firczuk M., Nowis D., Gołąb J.: PDT-induced inflammatory andhost responses. Photochem. Photobiol. Sci., 2011; 10: 653-663
  Google Scholar
• 29. Garg A.D., Krysko D.V., Vandenabeele P., Agostinis P.: DAMPsand PDT-mediated photo-oxidative stress: exploring the unknown.Photochem. Photobiol. Sci., 2011; 10: 670-680
  Google Scholar
• 30. Garg A.D., Krysko D.V., Verfaillie T., Kaczmarek A., Ferreira G.B.,Marysael T., Rubio N., Firczuk M., Mathieu C., Roebroek A.J., AnnaertW., Golab J., de Witte P., Vandenabeele P., Agostinis P.: A novelpathway combining calreticulin exposure and ATP secretion in immunogeniccancer cell death. EMBO J., 2012; 31: 1062-1079
  Google Scholar
• 31. Garg A.D., Nowis D., Golab J., Vandenabeele P., Krysko D.V., AgostinisP.: Immunogenic cell death, DAMPs and anticancer therapeutics:an emerging amalgamation. Biochim. Biophys. Acta, 2010; 1805:53-71
  Google Scholar
• 32. Giorgi C., Bonora M., Missiroli S., Poletti F., Ramirez F.G., MorcianoG., Morganti C., Pandolfi P.P., Mammano F., Pinton P.: Intravitalimaging reveals p53-dependent cancer cell death induced byphototherapy via calcium signaling. Oncotarget, 2015; 6: 1435-1445
  Google Scholar
• 33. Giorgi C., Bonora M., Sorrentino G., Missiroli S., Poletti F., SuskiJ.M., Ramirez F.G., Rizzuto R., Di Virgilio F., Zito E., Pandolfi P.P.,Wieckowski M.R., Mammano F., Del Sal G., Pinton P.: p53 at the endoplasmicreticulum regulates apoptosis in a Ca2+-dependent manner.Proc. Natl. Acad. Sci. USA, 2015; 112, 1779-1784
  Google Scholar
• 34. Gołąb J., Wilczyński G., Zagozdzon R., Stokłosa T., DąbrowskaA., Rybczyńska J., Wasik M., Machaj E., Ołda T., Kozar K., KamińskiR., Giermasz A., Czajka A., Lasek W., Feleszko W., Jakóbisiak M.: Potentiationof the anti-tumour effects of photofrin-based photodynamictherapy by localized treatment with G-CSF. Br. J. Cancer, 2000;82: 1485-491
  Google Scholar
• 35. Gollnick S.O., Evans S.S., Baumann H., Owczarczak B., Maier P.,Vaughan L., Wang W.C., Unger E., Henderson B.W.: Role of cytokinesin photodynamic therapy-induced local and systemic inflammation.Br. J. Cancer, 2003; 88: 1772-1779
  Google Scholar
• 36. Gollnick S.O., Owczarczak B., Maier P.: Photodynamic therapyand anti-tumor immunity. Lasers Surg. Med., 2006; 38: 509-515
  Google Scholar
• 37. Hendrzak-Henion J.A., Knisely T.L., Cincotta L., Cincotta E., CincottaA.H.: Role of the immune system in mediating the antitumoreffect of benzophenothi¬azine photodynamic therapy. Photochem.Photobiol., 1999; 69: 575-581
  Google Scholar
• 38. Huang Y.Y., Balasubramanian T., Yang E., Luo D., Diers J.R., BocianD.F., Lindsey J.S., Holten D., Hamblin M.R.: Stable synthetic bacteriochlorinsfor photodynamic therapy: role of dicyano peripheralgroups, central metal substitution (2H, Zn, Pd), and Cremophor ELdelivery. Chem. Med. Chem., 2012; 7: 2155-2167
  Google Scholar
• 39. Huang Y.Y., Mroz P., Zhiyentayev T., Sharma S.K., BalasubramanianT., Ruzié C., Krayer M., Fan D., Borbas K.E., Yang E., Kee H.L., KirmaierC., Diers J.R., Bocian D.F., Holten D., Lindsey J.S., Hamblin M.R.:In vitro photodynamic therapy and quantitative structure-activityrelationship studies with stable synthetic near-infrared-absorbingbacteriochlorin photosensitizers. J. Med. Chem., 2010; 53: 4018-4027
  Google Scholar
• 40. Jalili A., Makowski M., Switaj T., Nowis D., Wilczynski G.M., WilczekE., Chorazy-Massalska M., Radzikowska A., Maslinski W., BiałyL., Sienko J., Sieron A., Adamek M., Basak G., Mróz P., et al.: Effectivephotoimmunotherapy of murine colon carcinoma induced by thecombination of photodynamic therapy and dendritic cells. Clin.Cancer Res., 2004; 10: 4498-508
  Google Scholar
• 41. Kang R., Zeh H.J., Lotze M.T., Tang D.: The Beclin 1 network regulatesautophagy and apoptosis. Cell Death Differ., 2011; 18, 571-580
  Google Scholar
• 42. Kessel D., Luo Y.: Photodyanmic therapy: a mitochondrial inducerof apoptosis. Cell Death Differ., 1999; 6: 28-35
  Google Scholar
• 43. Kessel D., Luo Y., Deng Y., Chang C.K.: The role of subcellularlocalization in initiation of apoptosis by photodynamic therapy.Photochem. Photobiol., 1997; 65: 422-426
  Google Scholar
• 44. Kim K.S., Cho C.H., Park E.K., Jung M.H., Yoon K.S., Park H.K.:AFM-detected apoptotic changes in morphology and biophysicalproperty caused by paclitaxel in ishikawa and HeLa cells. PLoS One,2012; 7: e30066
  Google Scholar
• 45. Konopka K., Goslinski T.: Photodynamic therapy in dentistry. J.Dental. Res., 2007; 86: 694-707
  Google Scholar
• 46. Korbelik M.: PDT-associated host response and its role in thetherapy outcome. Lasers Surg. Med., 2006; 38: 500-508
  Google Scholar
• 47. Korbelik M., Cecic I.: Contribution of myeloid and lymphoidhost cells to the curative outcome of mouse sarcoma treatment byphotodynamic therapy. Cancer Lett., 1999; 137: 91-98
  Google Scholar
• 48. Korbelik M., Dougherty G.J.: Photodynamic therapy-mediatedimmune response against subcutaneous mouse tumors. Cancer Res.,1999; 59: 1941-1946
  Google Scholar
• 49. Korbelik M., Naraparaju V.R., Yamamoto N.: Macrophage-directedimmunotherapy as adjuvant to photodynamic therapy of cancer.Br. J. Cancer, 1997; 75: 202-207
  Google Scholar
• 50. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S.,Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., GreenD.R., Hengartner M., Knight R.A., Kumar S., Lipton S.A., Malorni W.,et al.: Classification of cell death. Cell. Death Differ., 2009; 16: 3-11
  Google Scholar
• 51. Krosl G., Korbelik M., Krosl J., Dougherty G.J.: Potentiation ofphotodynamic therapy-elicited antitumor response by localizedtreatment with granulocyte-macrophage colony-stimulating factor.Cancer Res., 1996; 56: 3281-3286
  Google Scholar
• 52. Kushibiki T., Tajiri T., Tomioka Y., Awazu K.: Photodynamic therapyinduces interleukin secretion from dendritic cells. In. J. Clin.Exp. Med., 2010; 3: 110-114
  Google Scholar
• 53. Lam M., Lee Y.J., Deng M., Hsia A.H., Morrissey K.A., Yan C.,Azzizudin K., Oleinick N.L., McCormick T.S., Cooper K.D., Baron E.D.:Photodynamic therapy with the silicon phthalocyanine Pc 4 inducesapoptosis in Mycosis fungoides and sezary syndrome. Adv. Hematol.,2010; 2010: 896161
  Google Scholar
• 54. Lee Y., Baron E.D.: Photodynamic therapy: current evidenceand applications in dermatology. Semin. Cutan. Med. Surg., 2011;30: 199-209
  Google Scholar
• 55. Lemasters J.J.: Dying a thousand deaths: redundant pathwaysfrom different organelles to apoptosis and necrosis. Gastroentrology,2005; 129: 351-360
  Google Scholar
• 56. Longo J.P., de Melo L.N., Mijan M.C., Valois C.R., Joanitti G.A.,Simioni A.R., Tedesco A.C., de Azevedo R.B.: Photodynamic therapymediated by liposomal chloroaluminum-phthalocyanine inducesnecrosis in oral cancer cells. J. Biomater. Tissue Eng., 2013; 3: 148-156
  Google Scholar
• 57. Longo J.P., Lozzi S.P., Simioni A.R., Morais P.C., Tedesco A.C., AzevedoR.B.: Photodynamic therapy with aluminum-chloro-phthalocyanineinduces necrosis and vascular damage in mice tongue tumors.J. Photochem. Photobiol. B., 2009; 94: 143-146
  Google Scholar
• 58. Magaraggia M., Faccenda F., Gandolfi A., Jori G.: Treatment ofmicrobiologically polluted aquaculture waters by a novel photochemicaltechnique of potentially low environmental impact. J. Environ.Monit., 2006; 8: 923-931
  Google Scholar
• 59. Maisch T., Spannberger F., Regensburger J., Felgenträger A.,Bäumler W.: Fast and effective: intense pulse light photodynamicinactivation of bacteria. J. Ind. Microbiol. Biotechnol., 2012; 39:1013-1021
  Google Scholar
• 60. Master A., Livingston M., Sen Gupta A.: Photodynamic nanomedicinein the treatment of solid tumors: perspectives and challenges.J. Control Release, 2013; 168: 88-102
  Google Scholar
• 61. Meisel P., Kocher T.: Photodynamic therapy for periodontal diseases:state of the art. J. Photochem. Photobiol. B., 2005; 79: 159-170
  Google Scholar
• 62. Mfouo-Tynga I., Houreld N.N., Abrahamse H.: Induced cell deathpathway post photodynamic therapy using a metallophthalocyanine photosensitizer in breast cancer cells. Photomed. LaserSurg., 2014; 32: 205-211
  Google Scholar
• 63. Michels S., Schmidt-Erfurth U.: Photodynamic therapy withverteporfin: a new treatment in ophthalmology. Semin. Ophthalmol.,2001; 16: 201-206
  Google Scholar
• 64. Moor A.C.: Signalling pathways in cell death and survival afterphotodynamic therapy. J. Photochem. Photobiol., B., 2000; 57: 1-13
  Google Scholar
• 65. Mroz P., Hashmi J.T., Huang Y.Y., Lange N., Hamblin M.R.: Stimulationof anti-tumor immunity by photodynamic therapy. Expert.Rev. Clin. Immunol., 2011; 7: 75-91
  Google Scholar
• 66. Mroz P., Huang Y.Y., Szokalska A., Zhiyentayev T., Janjua S., NifliA.P., Sherwood M.E., Ruzié C., Borbas K.E., Fan D., Krayer M., BalasubramanianT., Yang E., Kee H.L., Kirmaier C., et al.: Stable syntheticbacteriochlorins overcome the resistance of melanoma to photodynamictherapy. FASEB J., 2010; 24: 3160-3170
  Google Scholar
• 67. Mroz P., Yaroslavsky A., Kharkwal G.B., Hamblin M.R.: Cell deathpathways in photodynamic therapy of cancer. Cancers, 2011;3, 2516-2539
  Google Scholar
• 68. Nowis D., Makowski M., Stokłosa T., Legat M., Issat T., Gołab J.:Direct tumor damage mechanisms of photodynamic therapy. ActaBiochim. Pol., 2005; 52: 339-352
  Google Scholar
• 69. Nowis D., Stokłosa T., Legat M., Issat T., Jakóbisiak M., Gołab J.:The influence of photodynamic therapy on the immune response.Photodiagn. Photodyn. Ther., 2005; 2: 283-298
  Google Scholar
• 70. Nyman E.S., Hynninen P.H.: Research advances in the use oftetrapyrrolic photosensitizers for photodynamic therapy. J. Photochem.Photobiol. B, 2004; 73: 1-28
  Google Scholar
• 71. Ormond A.B., Freeman H.S.: Dye sensitizers for photodynamictherapy. Materials, 2013; 6: 817-840
  Google Scholar
• 72. Palucka K., Banchereau J.: Cancer immunotherapy via dendriticcells. Nat. Rev. Cancer, 2012; 12: 265-277
  Google Scholar
• 73. Paz-Cristobal M.P., Royo D., Rezusta A., Andrés-Ciriano E., AlejandreM.C., Meis J.F., Revillo M.J., Aspiroz C., Nonell S., Gilaberte Y.:Photodynamic fungicidal efficacy of hypericin and dimethyl methyleneblue against azole-resistant Candida albicans strains. Mycoses,2014; 57: 35-42
  Google Scholar
• 74. Pereira Gonzales F., Maisch T.: Photodynamic inactivation forcontrolling Candida albicans infections. Fungal Biol., 2012; 116: 1-10
  Google Scholar
• 75. Plaetzer K., Kiesslich T., Verwanger T., Krammer B:. The modesof cell death induced by PDT: an overview. Med. Laser Application,2003; 18: 7-19
  Google Scholar
• 76. Portilho F.A., Cavalcanti C.E., Miranda-Vilela A.L., EstevanatoL.L., Longo J.P., Santos M.F., Bocca A.L., Martins O.P., Simioni A.R., MoraisP.C., Azevedo R.B., Tedesco A.C., Lacava Z.G.: Antitumor activityof photodynamic therapy performed with nanospheres containingzinc-phthalocyanine. J. Nanobiotechnology, 2013; 11: 41
  Google Scholar
• 77. Pushpan S.K., Venkatraman S., Anand V.G., Sankar J., ParmeswaranD., Ganesan S., Chandrashekar T.K.: Porphyrins in photodynamictherapy: a search for ideal photosensitizers. Curr. Med. Chem.Anticancer Agents, 2002; 2: 187-207
  Google Scholar
• 78. Ricchelli F., Franchi L., Miotto G., Borsetto L., Gobbo S., NikolovP., Bommer J.C., Reddi E.: Mesosubstituted tetra-cationic porphyrinsphotosensitize the death of human fibrosarcoma cells via lysosomaltargeting. Int. J. Biochem. Cell Biol., 2005; 37: 306-319
  Google Scholar
• 79. Schraml B.U., Reis E., Sousa C.: Defining dendritic cells. Curr.Opin. Immunol., 2015; 32: 13-20
  Google Scholar
• 80. Silva J.N., Filipe P., Morlière P., Mazière J.C., Freitas J.P., GomesM.M., Santus R.: Photodynamic therapy: dermatology and ophthalmologyas main fields of current applications in clinic. Biomed. Mater.Eng., 2008; 18: 319-327
  Google Scholar
• 81. Sperandio F.F., Huang Y.Y., Hamblin M.R.: Antimicrobial photodynamictherapy to kill Gram-negative bacteria. Recent. Pat. Antiinfect. Drug Discov., 2013; 8: 108-120
  Google Scholar
• 82. St Denis T.G., Hamblin M.R.: Synthesis, bioanalysis and biodistributionof photosensitizer conjugates for photodynamic therapy.Bioanalysis, 2013; 5: 1099-1114
  Google Scholar
• 83. Sun J., Cecic I., Parkins C.S., Korbelik M.: Neutrophils as inflammatoryand immune effectors in photodynamic therapy-treatedmouse SCCVII tumours. Photochem. Photobiol. Sci., 2002; 1: 690-695
  Google Scholar
• 84. Szeimies R.M., Lischner S., Philipp-Dormston W., Walker T., Hiepe-WegenerD., Feise K., Podda M., Prager W., Kohl E., Karrer S.:Photodynamic therapy for skin rejuvenation: treatment options –results of a consensus conference of an expert group for aestheticphotodynamic therapy. J. Dtsch. Dermatol. Ges., 2013; 11: 632-636
  Google Scholar
• 85. Taub A.F.: Cosmetic clinical indications for photodynamic therapy.J. Cosmet. Dermatol., 2012; 25: 218-224
  Google Scholar
• 86. Thong P.S., Olivo M., Kho K.W., Bhuvaneswari R., Chin W.W., OngK.W., Soo K.C.: Immune response against angiosarcoma following lowerfluence rate clinical photodynamic therapy J. Environ. Pathol.Toxicol. Oncol., 2008; 27: 35-42
  Google Scholar
• 87. Wainwright M.: Local treatment of viral disease using photodynamictherapy. Int. J. Antimicrob. Agents, 2003; 21: 510-520
  Google Scholar
• 88. Wainwright M.: Pathogen inactivation in blood products. Curr.Med. Chem., 2002; 9: 127-143
  Google Scholar
• 89. Waksman R., McEwan P.E., Moore T.I., Pakala R., Kolodgie F.D.,Hellinga D.G., Seabron R.C., Rychnovsky S.J., Vasek J., Scott R.W., VirmaniR.: PhotoPoint photodynamic therapy promotes stabilizationof atherosclerotic plaques and inhibits plaque progression. J. Am.Coll. Cardiol., 2008; 52: 1024-1032
  Google Scholar
• 90. Wolfsen H.C.: Porfimer sodium photodynamic therapy: the longroad to acceptance in America. Photodiagnosis Photodyn. Ther.,2007; 4: 242-243
  Google Scholar
• 91. Wood S.R., Holroyd J.A., Brown S.B.: The subcellular localizationof Zn (II) phthalocyanines and their redistribution on exposure tolight. Photochem. Photobiol., 1997; 65: 397-402
  Google Scholar
• 92. Woodburn K.W., Fan Q., Kessel D., Wright M., Mody T.D., HemmiG., Magda D., Sessler J.L., Dow W.C., Miller R.A., Young S.W.: Phototherapyof cancer and atheromatous plaque with texaphyrins. J.Clin. Laser Med. Surg., 1996; 14: 343-348
  Google Scholar
• 93. Yang E., Diers J.R., Huang Y.Y., Hamblin M.R., Lindsey J.S., BocianD.F., Holten D.: Molecular electronic tuning of photosensitizers toenhance photodynamic therapy: synthetic dicyanobacteriochlorinsas a case study. Photochem. Photobiol., 2013; 89: 605-618
  Google Scholar

Pełna treść artykułu